Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014

Strong Second Quarter

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

Moberg Pharma (STO:MOB):

FIRST SIX MONTHS (JAN-JUN 2014)

· Revenue MSEK 105.5 (83.4)

Help employers find you! Check out all the jobs and post your resume.